AUP-5550

N/A

Report date: 2025/01/26 19:30:05
NME

Base Information

Drug NameAUP-5550
Drug Alias Nameanti-cancer/anti-inflammatory therapeutics (Aurealis)AUP-5550
ClassificationNatural product/ExtractSmall molecules
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsInflammationNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFinland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAurealis
China Registration ClassN/A

Develop Information

Active CompaniesAurealis
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsInflammation

Other Information

ATC CodeN/A
Related LinksN/A